The JI PBL Intereron Source
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Davenport, C.
Right arrow Articles by Bennett, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Davenport, C.
Right arrow Articles by Bennett, M.

The Journal of Immunology, Vol 155, Issue 8 3742-3749, Copyright © 1995 by American Association of Immunologists


ARTICLES

Rapid rejection of H2k and H2k/b bone marrow cell grafts by CD8+ T cells and NK cells in irradiated mice

C Davenport, V Kumar and M Bennett
Department of Pathology, University of Texas Southwestern Medical Center, Dallas, TX 75235, USA.

Acute rejection of transplanted bone marrow cell (BMC) grafts can occur within 48 h in unsensitized, lethally irradiated mice, and NK cells have been implicated as the effector cells. Recently, we observed that both CD8+ TCR-alpha beta+ T and NK cells of irradiated mice could rapidly reject allogeneic lymph node cell grafts. In this study, we evaluated the ability of NK and CD8+ T cells to mediate rejection of H2k or H2k/b BMC grafts by pretreating groups of mice with depleting mAbs. H2k BMC were transplanted into syngeneic, B6 (H2b), BALB/c (H2d), NZB (H2d), and (NZB x B6)F1 (NZB6F1, H2d/b) hosts. Proliferation measured 5 days after cell transfer indicated that syngeneic, B6, and BALB/c hosts accepted H2k BMC grafts. However, CD8+ T cells from NZB and poly I:C-treated BALB/c hosts, and NK cells from poly I:C-treated NZB6F1, hosts, rejected H2k BMC grafts. In NZB6F1 hosts, there was an added effect of anti-TCR-alpha beta and anti-NK1.1 mAbs. It is possible that T and NK cells cooperate in rejecting H2k or H2k/b BMC grafts in certain hosts. Transplantation of H2k/b, but not H2k/d, BMC into similar recipients had the same fate as H2k BMC. Thus, certain CD8+ T cells may share a similar recognition system with NK cells.


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. H. Johansson, M. A. Taylor, M. Jagodic, K. Tus, J. D. Schatzle, E. K. Wakeland, and M. Bennett
Mapping of Quantitative Trait Loci Determining NK Cell-Mediated Resistance to MHC Class I-Deficient Bone Marrow Grafts in Perforin-Deficient Mice
J. Immunol., December 1, 2006; 177(11): 7923 - 7929.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
I. Barao, A. M. Hanash, W. Hallett, L. A. Welniak, K. Sun, D. Redelman, B. R. Blazar, R. B. Levy, and W. J. Murphy
Suppression of natural killer cell-mediated bone marrow cell rejection by CD4+CD25+ regulatory T cells
PNAS, April 4, 2006; 103(14): 5460 - 5465.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. A. Brehm, K. A. Daniels, J. R. Ortaldo, and R. M. Welsh
Rapid Conversion of Effector Mechanisms from NK to T Cells during Virus-Induced Lysis of Allogeneic Implants In Vivo
J. Immunol., June 1, 2005; 174(11): 6663 - 6671.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. T. Ildstad, P. M. Chilton, H. Xu, M. A. Domenick, and M. B. Ray
Preconditioning of NOD mice with anti-CD8 mAb and costimulatory blockade enhances chimerism and tolerance and prevents diabetes, while depletion of {alpha}{beta}-TCR+ and CD4+ cells negates the effect
Blood, March 15, 2005; 105(6): 2577 - 2584.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
H. Xu, B. G. Exner, P. M. Chilton, C. Schanie, and S. T. Ildstad
CD45 Congenic Bone Marrow Transplantation: Evidence for T Cell-Mediated Immunity
Stem Cells, November 1, 2004; 22(6): 1039 - 1048.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
M. Mammolenti, S. Gajavelli, P. Tsoulfas, and R. Levy
Absence of Major Histocompatibility Complex Class I on Neural Stem Cells Does Not Permit Natural Killer Cell Killing and Prevents Recognition by Alloreactive Cytotoxic T Lymphocytes In Vitro
Stem Cells, November 1, 2004; 22(6): 1101 - 1110.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
M. Komatsu, M. Mammolenti, M. Jones, R. Jurecic, T. J. Sayers, and R. B. Levy
Antigen-primed CD8+ T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1-, and TRAIL-dependent killing
Blood, May 15, 2003; 101(10): 3991 - 3999.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Xu, B. G. Exner, D. E. Cramer, M. K. Tanner, Y. M. Mueller, and S. T. Ildstad
CD8+, {alpha}{beta}-TCR+, and {gamma}{delta}-TCR+ Cells in the Recipient Hematopoietic Environment Mediate Resistance to Engraftment of Allogeneic Donor Bone Marrow
J. Immunol., February 15, 2002; 168(4): 1636 - 1643.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. Liu, M. A. Morris, P. Nguyen, T. C. George, E. Koulich, W. C. Lai, J. D. Schatzle, V. Kumar, and M. Bennett
Ly49I NK Cell Receptor Transgene Inhibition of Rejection of H2b Mouse Bone Marrow Transplants
J. Immunol., February 15, 2000; 164(4): 1793 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. C. George, L. H. Mason, J. R. Ortaldo, V. Kumar, and M. Bennett
Positive Recognition of MHC Class I Molecules by the Ly49D Receptor of Murine NK Cells
J. Immunol., February 15, 1999; 162(4): 2035 - 2043.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
D. H. Fowler, B. Whitfield, M. Livingston, P. Chrobak, and R. E. Gress
Non-Host-Reactive Donor CD8+ T Cells of Tc2 Phenotype Potently Inhibit Marrow Graft Rejection
Blood, June 1, 1998; 91(11): 4045 - 4050.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1995 by The American Association of Immunologists, Inc. All rights reserved.